Montene 4 mg

Prophylaxis and long-term treatment of asthma. Relief of symptoms of seasonal and perennial allergic rhinitis. Prevention of exercise-induced bronchoconstriction.

Montelukast selectively blocks the cysteinyl leukotriene (CysLT1) receptor. Leukotrienes cause airway swelling, smooth muscle contraction and inflammation in asthma and allergic rhinitis; blocking them reduces these effects.

Adult and adolescent 15 years and over: 10 mg once daily in the evening. Child 6-14 years: 5 mg chewable tablet once daily in the evening. Child 2-5 years: 4 mg chewable tablet once daily in the evening.

Headache, abdominal pain, thirst, diarrhoea, fever and upper respiratory tract infection. Sleep disturbance, abnormal dreams, agitation and mood changes are uncommon.

Not for relief of an acute asthma attack; keep a reliever inhaler available. Do not replace inhaled or oral corticosteroids abruptly. Report any change in mood or behaviour.

Hypersensitivity to montelukast or any ingredient of the preparation.

Store below 30°C in a cool, dry place, away from light. Keep out of the reach of children.